ABG Innovation Capital Partners III GP Ltd

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), ABG Innovation Capital Partners III GP Ltd reported 3 stock positions worth $832 thousand. Its top holding was Castle Biosciences (CSTL) at 89.5% of the portfolio, followed by Whitehawk Therapeutics (WHWK, 7.5%) and Synlogic (SYBX, 3.0%). Compared with Q4 2023, it reduced 1. The biggest sale was Castle Biosciences (CSTL, shares −8%).

Most Recent 13F
Q2 2026
Location
CENTRAL, HONG KONG, K3
CIK
0001845297
Portfolio Value
$832K (Q1 2024)
SEC Filing
0000950123-24-005237 ↗ filed May 15, 2024

Holdings Value

0$500K$1.0M$1.5M Q1 2024: $832K $832K Q1 2024 Q2 2024: $860K Q2 2024 Q3 2024: $1.1M Q3 2024 Q4 2024: $1.1M Q4 2024 Q1 2025: $800K Q1 2025 Q2 2025: $50K Q2 2025 Q3 2025: $51K Q3 2025 Q4 2025: $65K Q4 2025 Q1 2026: $0 Q1 2026 Q2 2026: $0 Q2 2026

Holdings 3 stocks · $832K
CSTL Castle Biosciences Inc. 89.54% 33,626 $745K Reduce -8.5%
WHWK Whitehawk Therapeutics Inc. filed as AADI BIOSCIENCE INC 7.50% 26,666 $62K No change
SYBX Synlogic Inc. 2.95% 13,727 $25K No change

Portfolio Sells Q4 2023 → Q1 2024
CSTL Castle Biosciences Inc. Reduce -8.5% 89.54% +1.41

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 0$0
Q1 2026 0$0
Q4 2025 1$65KWHWK
Q3 2025 1$51KWHWK
Q2 2025 1$50KWHWK
Q1 2025 3$800KCSTL, WHWK, SYBX
Q4 2024 3$1.1MCSTL, WHWK, SYBX
Q3 2024 3$1.1MCSTL, WHWK, SYBX
Q2 2024 3$860KCSTL, WHWK, SYBX
Q1 2024 3$832KCSTL, WHWK, SYBX